Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).

Dyda DaoTyler ZemlaAminah JatoiRachel A FreedmanArti HurriaHyman MussHarvey Jay CohenLawrence N ShulmanMarc CitronDaniel BudmanRyan McMurrayAnn PartridgeLisa CareyMina S SedrakJacqueline M LafkyJennifer G Le-Rademacher

Published in: The oncologist (2019)

Older-patient-specific trials appear to address this underrepresentation of older patients with ostensibly comparable outcomes. Clinical trial identification numbers. NCT00003088 (CALGB 9741); NCT00024102 (CALGB 49907); NCT00068601 (CALGB 40401); NCT00005970 (NCCTG N9831) IMPLICATIONS FOR PRACTICE: This work underscores the importance of clinical trials that focus on the recruitment of older patients with cancer.

Keyphrases

clinical trial
community dwelling
middle aged
physical activity
end stage renal disease
primary care
newly diagnosed
phase ii
type diabetes
prognostic factors
randomized controlled trial
skeletal muscle
young adults
double blind
squamous cell carcinoma
phase iii
weight loss
lymph node metastasis
squamous cell